A significant portion of each group (27%) were considered high-risk patients, if they had undergone allogenic stem cell transplantation or had relapsed acute leukemia.

• 在两个小组中，都有显著比例患者被认为是高危患者(27%25)，如他们为异基因移植后或白血病复发的病人。